Left atrial appendage occlusion with lambre in atrial fibrillation: Initial European experience.
暂无分享,去创建一个
Deyuan Zhang | Barbara E. Stähli | Anning Li | Johannes Brachmann | Deyuan Zhang | J. Brachmann | H. Sievert | Y. Lam | Horst Sievert | L. Vaskelyte | Yat-Yin Lam | Jai-Wun Park | B. Stähli | Caroline Kleinecke | Laura Vaskelyte | Steffen Schnupp | Kolja Sievert | K. Sievert | Jai-Wun Park | A. Li | S. Schnupp | C. Kleinecke
[1] S. Kische,et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry , 2016, European heart journal.
[2] Deyuan Zhang,et al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model. , 2013, International journal of cardiology.
[3] Tommy Andersson,et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study , 2013, European heart journal.
[4] J. Saw,et al. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug. , 2017, JACC. Cardiovascular interventions.
[5] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[6] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[7] Bernhard Meier,et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] K. Chun,et al. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study , 2018, Journal of cardiovascular electrophysiology.
[9] Y. Lam. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. , 2013, Cardiovascular revascularization medicine : including molecular interventions.
[10] K. Cao,et al. STRUCTURAL : ATRIAL INTERVENTION FOCUS Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation A Prospective , Multicenter Clinical Study , 2022 .
[11] B. Meier,et al. Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥ 75 Years. , 2016, The American journal of cardiology.
[12] Randall J. Lee,et al. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[13] Saibal Kar,et al. Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.
[14] M. Price,et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. , 2014, Journal of the American College of Cardiology.
[15] B. Meier,et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[16] B. Schmidt,et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[17] Saibal Kar,et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.